Clinical evaluation of the impact of rectal and bladder filling on prostate position during hypofractionated radiotherapy for prostate cancer
Explore this paper's citation graph
Summary
It is demonstrated that a full rectum shifted the prostate mainly anterosuperiorly, and the rectal volume’s impact on prostate movement is much larger than that of the bladder.
- Type
- article
- Published
- 2022-02-01
- Cited by
- 0
- References
- 23
- OpenAlex
- https://openalex.org/W4313042905
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:243856859
Keywords
Rectum, Prostate, Medicine, Prostate cancer, Fiducial marker
References
- Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy
- Intrafractional prostate motion during external beam radiotherapy monitored by a real‐time target localization system
- Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration.
- Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy.
- Target position variability throughout prostate radiotherapy.
- Analysis of prostate and seminal vesicle motion: implications for treatment planning.
- A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer.
- Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder.
- Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.
- Bladder extension variability during pelvic external beam radiotherapy with a full or empty bladder.
- Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning.
- Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder.
- Prostate target volume variations during a course of radiotherapy.
- Image-guided radiotherapy with implanted markers and kilovoltage imaging and 6-dimensional position corrections for intrafractional motion of the prostate.
- Prostate motion during standard radiotherapy as assessed by fiducial markers.
- [Quantification of prostate movements during radiotherapy].
- Long-term patient reported outcomes from a phase III randomized prospective trial of conventional versus hypofractionated radiotherapy for localized prostate cancer
- Strategies to evaluate the impact of rectal volume on prostate motion during three-dimensional conformal radiotherapy for prostate cancer
- Movements of the prostate due to rectal and bladder distension: implications for radiotherapy.
- Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.
Cited by
No citing papers recorded for this paper.
Related papers
- Su1993 EUS-Guided Fiducial Markers Placed by Pre-Loaded Fiducial Needles Have Significantly Increased Visibility Relative to Back-Loaded Fiducial Needles in Pancreatic Cancer
- SU-FF-J-34: Influence of Volumes of Prostate, Rectum and Bladder On Treatment Planning CT-Day On Inter-Fraction Motion of Prostate During BAT Image-Guided IMRT
- Image-guided radiation therapy for prostate cancer: A computed tomography-based assessment of fiducial marker migration between placement and 7 days.
- Dynamic Anatomy: The Three Sides of the Bermuda Triangle
- Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
- Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies
- A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue
- THE EXPRESSIONS OF MITOSIS REGULATIVE FACTOR STK-15 IN PROSTATE CANCER
- CSR1 Suppresses Tumor Growth and Metastasis of Prostate Cancer